Oxiris treatment for kidney injury from sepsis
Part of Infections, Kidney & urinary clinical trials.
This trial tests Oxiris, a blood-filtering device, in adults whose kidneys have suddenly stopped working due to a serious infection (sepsis). The goal is to see if this treatment helps the kidneys recover and improves overall survival.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 19 years old and no older than 85
- You have acute kidney injury (sudden loss of kidney function) caused by sepsis (a life-threatening infection)
- You do not have cancer that is not responding to treatment
- Your kidneys are not completely and permanently failed
- Your liver and heart are not in end-stage failure requiring advanced life support or transplant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks back at how a special kidney filter called oXiris helped patients in the ICU who had septic shock (a life-threatening blood infection) and kidney failure. Researchers want to understand if this filter improved survival and recovery compared to standard treatment.
This study looks at how stable blood pressure and heart rhythm are in people with sepsis who need continuous kidney filtration. If you qualify, it may help researchers better improve care for critically ill patients receiving this treatment.
This trial tests a special blood-filtering device (OXiris) for people with severe abdominal infections that cause septic shock and kidney damage. It aims to see if this treatment can help control the infection and improve recovery.
This study tests a special blood filter (Oxiris) to see if it helps clean the blood in people with septic shock. If you are receiving blood purification therapy, this filter might help your body recover better.
This trial tests a special blood filter called Oxiris that may help remove toxins and inflammation from the blood in patients with septic shock. It aims to see if this treatment can improve outcomes for people who need kidney replacement therapy.
This trial tests whether a special type of dialysis filter (oXiris) helps reduce blood clotting problems in patients with septic shock and kidney failure. It may offer a better option for those needing kidney support in the ICU.
Hear when a new Sepsis-associated AKI trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.